PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-06-29

Date Title Company
29-Jun-2023 BHV Partners, venture builder specialising in health, opens a round of €2.5 million to accelerate its growth BHV Partners
29-Jun-2023 Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting Kinarus Therapeutics Holding AG
29-Jun-2023 The Methodical Group Named 50 Fastest Growing Companies of 2023 Newswire
29-Jun-2023 Early Toxicity Testing Market Booming Worldwide with Latest Trend and Future Scope by 2030 The Wire Times
29-Jun-2023 SGD Pharma’s latest annual sustainability report details global environmental, social and ethical efforts SGD Pharma
29-Jun-2023 EIT Health brings its European innovation community and expertise to Paris Saclay Cancer Cluster start-ups EIT Health
29-Jun-2023 Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange Laekna, Inc
29-Jun-2023 Cantourage Group SE sets corporate record: four new cultivation partners within a month Cantourage Group SE
29-Jun-2023 BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development Newswire
29-Jun-2023 BONESUPPORT launches next generation of CERAMENT® G BONESUPPORT
29-Jun-2023 Mainz Biomed Secures up to $50M in New Funding Mainz Biomed
29-Jun-2023 Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million Vesalius Biocapital
29-Jun-2023 Successful Artificial Intelligence led programme identifies multiple influenza drug targets Poolbeg Pharma
29-Jun-2023 Covid fatalities plummet, as dementia and heart disease become No 1 killers London Medical Laboratory
29-Jun-2023 Tower Cold Chain Expands Presence with Opening of American Centre of Excellence Tower Cold Chain
29-Jun-2023 Bone Growth Stimulators Market Trends 2023: Projected to Surpass USD 3.3 Billion by 2030, Claims AMR The Wire Times
29-Jun-2023 Immutep completes AUD 80 million capital raise Immutep
29-Jun-2023 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS.1 Eli Lilly and Company
29-Jun-2023 Locum pharmacy pay rates rise by a fifth amid growing workloads and pressures Locate a Locum
29-Jun-2023 European Patent Office Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies ONK Therapeutics